Side-by-side comparison of AI visibility scores, market position, and capabilities
Cambridge MA energy equipment spin-off from GE (NYSE: GEV) at $34.9B revenue 2024; 7,000+ gas turbines and 55,000 wind turbines generating 25-30% of global electricity competing with Siemens Energy and Vestas for energy transition equipment.
GE Vernova is a Cambridge, Massachusetts-based global energy equipment and services company — publicly traded on the New York Stock Exchange (NYSE: GEV) — that emerged as an independent entity in April 2024 following its spin-off from General Electric, employing approximately 75,000 people across 100 countries and focused on accelerating the energy transition through three core business segments: Power (gas turbines, nuclear, and steam solutions), Wind (onshore and offshore wind turbines), and Electrification (grid solutions, power conversion, and electrification software). Generating $34.9 billion in revenue in 2024 with strong growth across all segments, GE Vernova operates more than 7,000 gas turbines and 55,000 wind turbines globally — equipment that generates approximately 25-30% of the world's electricity.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.